World Enteric Disease Testing Market - Opportunities & Forecasts to 2022 - Companies Shifting from Conventional to Advanced Diagnostics & Treatments - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "World Enteric Disease Testing Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.

Enteric disease is a condition caused in the intestine due to the presence of foreign antigen such as bacterial, viral and parasites. The enteric diseases are commonly caused due to E-coli, Vibro Cholerae salmonella, shigella, rotavirus, and norovirus. The most influencing factor being hygiene is getting worse due to the increasing population, especially in urban areas of developing economies.

Several factors such as unsafe drinking water, poor sanitation and unhygienic conditions are increasing the prevalence of enteric diseases. In order to overcome the severity of these diseases, the companies are shifting their trends from conventional to more advanced diagnostics and treatments. The companies are adopting various strategies for the development of novel therapeutics and testing technologies for enteric diseases. The report analyzes these key strategies of leading players. Government regulation and reimbursement scenarios for the enteric disease are dealt according to geographies. The enteric disease testing market's external environment has been studied in order to provide intelligence to decision markers.

The market enteric disease testing market is hindered due to high cost of equipments and labors, and mandatory requirement for sophisticated laboratory conditions for clinical diagnostics. These challenges are expected to be resolve in future with the emergence of various advance cost effective technologies such as enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR). Furthermore, increase in intervention from the governments to improve the living standard in people is expected to influence the market positively. The government authorities are chiefly responsible for shifting the trend of conventional diagnostic to advance methods.

Key companies included in the report:

  • Alere
  • Becton Dickinson & Company
  • Biomerica
  • Biomerieu
  • Bio-Rad
  • Cepheid Coris Bioconcept
  • Diasorin
  • Meridian Bioscience
  • Quest Diagnostics
  • Trinity Biotech

For more information about this report visit http://www.researchandmarkets.com/research/bvtjp6/world_enteric

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Disease Testing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Infectious Disease Testing